Oncolytic viruses, which can selectively deliver transgenes to tumors, were leveraged by Park et al. to develop a virus expressing a truncated, non-signaling CD19 (CD19t) protein, which was then used to infect tumor cells [47]. The gene discussed is CD19; the disease is neoplasm.